Table 1 Pretreatment characteristics of the patients
Patient ID | Age | Weight (kg) | Genotype | Gender | Fibrosis Score Metavir | ALT (IU/L) | Day 1 HCV RNA level (IU/Ml) |
|---|---|---|---|---|---|---|---|
1 | 49 | 76 | 1a | 1 | 4 | 74 | 1.7E+06 |
2 | 52 | 92 | 1a | 0 | 0 | 20 | 7.0E+05 |
3 | 52 | 92 | 1a | 1 | 4 | 57 | 3.4E+06 |
4 | 38 | 90 | 1a | 1 | 0 | 52 | 1.1E+07 |
5 | 56 | 80 | 1a | 1 | 2 | 68 | 3.5E+06 |
6 | 47 | 106 | 1a | 1 | 3 | 146 | 1.1E+07 |
7 | 44 | 65 | 1b | 1 | 2 | 127 | 1.1E+07 |
8 | 42 | 112 | 1a | 1 | 1 | 67 | 7.2E+06 |
9 | 52 | 78 | 1a | 1 | 4 | 71 | 2.3E+06 |
10 | 57 | 76 | 1b | 0 | 2 | 68 | 7.1E+06 |
11 | 59 | 70 | 1b | 0 | 3 | 62 | 2.4E+06 |
12 | 56 | 109 | 1a | 1 | 4 | 74 | 5.8E+06 |
13 | 49 | 116 | 1a | 1 | 2 | 44 | 5.8E+06 |
14 | 53 | 90 | 1b | 1 | 4 | 98 | 3.7E+05 |
15 | 51 | 61 | 1a | 0 | 3 | 73 | 1.8E+06 |
16 | 50 | 78 | 1a | 1 | 3 | 99 | 1.6E+06 |
17 | 60 | 106 | 1a | 1 | 2 | 37 | 4.1E+05 |
18 | 45 | 114 | 1a | 1 | 4 | 161 | 9.0E+05 |
19 | 47 | 74 | 1b | 1 | 3 | 117 | 4.0E+05 |
20 | 61 | 83 | 1b | 1 | 2 | 181 | 8.1E+05 |